Indo US Bio-TechNSE:INDOUS +1.02%63 Quick Ratio is 0.52 as of Mar. 2026, which is 56% below its 10-year median of 1.17. GuruFocus rates NSE:INDOUS with a GF Score™ of 63/100 and a GF Value™ of ₹198.23 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 260 Agriculture companies, Indo US Bio-Tech ranks worse than 86.54% on this metric.
Indo US Bio-Tech has a quick ratio of 0.52. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for Indo US Bio-Tech's Quick Ratio or its related term are showing as below:
NSE:INDOUS'
s Quick Ratio Range Over the Past 10 Years
Min: 0.52 Med: 1.17 Max: 2.68
Current: 0.52
During the past 13 years, Indo US Bio-Tech's highest Quick Ratio was 2.68. The lowest was 0.52. And the median was 1.17.
NSE:INDOUS's Quick Ratio is ranked worse than 86.54% of 260
companies
in the Agriculture industry
Industry Median: 1.01
vs NSE:INDOUS: 0.52
Indo US Bio-Tech (NSE:INDOUS) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Indo US Bio-Tech Quick Ratio Related Terms
Indo US Bio-Tech Quick Ratio Historical Data
* Premium members only.
The historical data trend for Indo US Bio-Tech's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:INDOUS vs CTVA, CF, MOS: Quick Ratio Comparison
For the Agricultural Inputs subindustry, Indo US Bio-Tech's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indo US Bio-Tech Quick Ratio vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Indo US Bio-Tech's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Indo US Bio-Tech's Quick Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indo US Bio-Tech (NSE:INDOUS) has a Quick Ratio of 0.52 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Indo US Bio-Tech and its competitors. This is 56% below median its historical median of 1.17. Over the past decade, Indo US Bio-Tech's Quick Ratio has ranged from 0.52 to 2.68. According to the industry distribution chart, Indo US Bio-Tech ranks #225 out of 260 companies in the Agriculture industry, placing it in the top 86.5%.
Is Indo US Bio-Tech's Quick Ratio too high?
Indo US Bio-Tech's current Quick Ratio of 0.52 is 56% below median its 10-year median of 1.17. Over the past 10 years, this metric has ranged from a low of 0.52 to a high of 2.68. The Agriculture industry median Quick Ratio is 1.01. Indo US Bio-Tech's value of 0.52 is 48.5% below this industry median. Based on the distribution chart, Indo US Bio-Tech ranks #225 out of 260 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, Indo US Bio-Tech has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's Quick Ratio compare to CTVA and CF?
According to the Agriculture industry distribution chart, Indo US Bio-Tech ranks #225 out of 260 companies for Quick Ratio. This places Indo US Bio-Tech in the lower half of its industry. The industry median Quick Ratio is 1.01. Indo US Bio-Tech's value of 0.52 is 48.5% below this benchmark. Historically, Indo US Bio-Tech's own Quick Ratio has ranged from 0.52 to 2.68 over the past decade. While the company's 10-year median is 1.17 vs. the industry median of 1.01, Indo US Bio-Tech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for an Agriculture company?
The median Quick Ratio among Agriculture companies is 1.01, based on 260 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indo US Bio-Tech's current Quick Ratio of 0.52 is 48.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Indo US Bio-Tech and its competitors. For the Agriculture industry, the median Quick Ratio is 1.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indo US Bio-Tech's current Quick Ratio is 0.52, which is 56% below median its own 10-year median of 1.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (NSE:INDOUS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹198.23, compared to a current price of ₹88.48 — trading 55.4% below its estimated fair value. The current Quick Ratio is 0.52, which is 56% below median its 10-year median of 1.17 and 48.5% below the Agriculture industry median of 1.01. Indo US Bio-Tech's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Indo US Bio-Tech (NSE:INDOUS), the current Quick Ratio is 0.52 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indo US Bio-Tech (NSE:INDOUS) Overvalued in 2026?
Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued.
The current stock price of ₹88.48 is trading 55.4% below its estimated GF Value™ of ₹198.23.
GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.
Key valuation signals for NSE:INDOUS:
Quick Ratio: 0.52 (56% below median its 10-year median of 1.17)
GF Value™: ₹198.23 vs. price of ₹88.48 (55.4% below fair value)
Industry Position: 48.5% below the Agriculture median (#225 of 260)
No single metric tells the full story. See the NSE:INDOUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
63GF Score
Get the complete analysis for NSE:INDOUS
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDOUS has been successfully added to your 
